Health U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease James Pereira Dec 10, 2023 The U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in… Read More...
Health ‘Real estate’ for corals: Swiss organisation builds artificial reefs with art, tech James Pereira Dec 1, 2023 3D-printed clay sculptures that provide shelter to corals are part of an innovative, artistic… Read More...
Health Brains have a remarkable ability to rewire themselves following injury − a concussion specialist… James Pereira Nov 15, 2023 High-profile sports like football and soccer have brought greater attention in recent years to concussions – the… Read More...
Sports Tamil Nadu Sports Science International Conclave concludes Amelia Podder Nov 14, 2023 The two-day Tamil Nadu Sports Science International Conclave 2023 (TASCon 2023) concluded on Wednesday. | Photo Credit:!-->>-->!-->>-->… Read More...
Health Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events James Pereira Nov 13, 2023 Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be… Read More...
Technology Become a master of Excel, VBA, and Data Science for just $20 Kevin Colleran Nov 8, 2023 Being able to work with data is an incredibly valuable skill in today’s data-driven workplace. Having a… Read More...
Education 20 Guiding Questions For Climate Change Nick J Adam Nov 6, 2023 The classroom’s role in empowering the future climate workforce contributed by Bob Powell, founder and CEO,… Read More...
Technology ‘Take Science Fiction Seriously’: World Leaders Sound Alarm on AI Kevin Colleran Nov 2, 2023 Updated Nov. 1, 2023 12:29 pm ETBLETCHLEY, U.K.—Here in the English countryside, at an estate where World War II… Read More...
Education Biological sex is far from binary − this college course examines the science of sex diversity in… Nick J Adam Oct 26, 2023 Uncommon Courses is an occasional… Read More...
Health NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies James Pereira Aug 1, 2023 Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture… Read More...